PAVmed's Upcoming Business Update Conference Call
Join PAVmed Inc. (NASDAQ: PAVM) for a critical business update conference call and webcast on November 13. The call is set to begin at 8:30 AM Eastern Time and offers a chance for investors and stakeholders to hear directly from PAVmed's leadership.
What to Expect from the Call
During this event, Dr. Lishan Aklog, the CEO and Chairman of PAVmed, will provide invaluable insights into the company's current operations and its strategic plans for growth. This update is particularly essential for understanding how PAVmed is navigating the ever-evolving landscape of medical technology.
A Deep Dive into the Company's Financials
Additionally, Dennis McGrath, the President and Chief Financial Officer, will present a detailed report on the company's third-quarter financial results. Those keen on the financial health and plans of PAVmed shouldn't miss this opportunity to hear directly from the executives steering the organization.
Accessing the Conference Call and Webcast
Investors interested in joining the conference call can do so via telephone by dialing 1-800-836-8184 in the U.S. For international callers, the number is 1-646-357-8785. When connecting, listeners should mention the conference call name “PAVmed Business Update” to the operator. The webcast will also be accessible through the investor relations section available on the company's main website.
Replay Availability
For those unable to attend the live call, a replay will be accessible for 30 days post-event via the investor relations section of PAVmed’s website. This ensures that stakeholders can stay informed about the company's developments and responses to the market conditions.
About PAVmed Inc.
PAVmed Inc. is a distinguished commercial-stage medical technology company engaged in medical devices, diagnostics, and digital health sectors. Among its notable subsidiaries is Lucid Diagnostics (NASDAQ: LUCD), offering innovative solutions such as the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device, aimed at early detection of esophageal cancer. Furthermore, Veris Health Inc., another subsidiary, focuses on enhancing personalized cancer care through advanced remote monitoring technologies, an essential investment in patient care.
Stay Updated with PAVmed
For continuous news and updates about PAVmed and its subsidiaries, visit the company's official websites. Notably, the web broadcasts will allow participants to engage in the conversation surrounding the latest innovations and results within the medical sector.
Frequently Asked Questions
1. When is the PAVmed conference call scheduled?
The conference call is scheduled for November 13 at 8:30 AM Eastern Time.
2. How can I access the conference call?
You can join by phone at 1-800-836-8184 in the U.S. or 1-646-357-8785 internationally.
3. Will the call be available for replay?
Yes, a replay will be available for 30 days on PAVmed’s investor relations webpage.
4. Who will be speaking at the conference call?
Dr. Lishan Aklog and Dennis McGrath will provide updates during the call.
5. What is PAVmed's focus?
PAVmed focuses on developing medical technologies, diagnostics, and digital health solutions for improved patient care.